In Case You Missed It: Additional Abstracts of Interest From AACR

1. The VICTORI study was an observational trial on liquid biopsy informed by ctDNA assay in colorectal cancer.

2. A KRAS G12D Inhibitor showed encouraging results as a treatment for NSCLC.

3. A topical gel may be a potential treatment for skin rash from EGFR inhibitors.

4. The combination of PARP and PD-1 inhibition showed promising results for patients with advanced disease.

5. The SKYSCRAPER-01 trial investigated tiragolumab plus atezolizumab in PD-L1–high NSCLC.